Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | TLR9 | Q9NR96 | 3/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.64 |
| ▸ | ATM | Q13315 | 2/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
| ▸ | PKM | P14618 | 1/20 | 0.64 |
| ▸ | CCR6 | P51684 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | MGLL | Q99685 | 11/20 | 0.55 |
| ▸ | MITF | O75030 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29364136 | 0.82 | ALDH1A1 (0.71) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL183052 | 0.82 | ALDH1A1 (0.71) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL7165238 | 0.81 | TLR9 (0.64) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL29510541 | 0.81 | TLR9 (0.64) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL11324489 | 0.81 | TLR9 (0.64) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL9240798 | 0.81 | TLR9 (0.64) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| Hydrochloric Acid SCHEMBL6753288 | 0.81 | ALDH1A1 (0.69) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL10938557 | 0.81 | ALDH1A1 (0.64) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL28267017 | 0.80 | ALDH1A1 (0.60) | ALDH1A1TLR9HSP90AA1ATMNPSR1 | |
| SCHEMBL2210131 | 0.79 | APEX1 (0.53) | ALDH1A1TLR9HSP90AA1ATMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104031354-B | Resin combination and use its prepreg made and laminate | 苏州生益科技有限公司 | 2016-08-03 | — | — | CN | disclosed |
| US-8765012-B2 | Thermosetting composition and printed circuit board using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2014-07-01 | — | — | US | disclosed |
| US-20100147689-A1 | METHOD FOR MODIFYING SURFACE OF ALUMINUM OXIDE AND ELECTROOSMOSIS PUMP AND ELECTRIC POWER GENERATOR USING MODIFIED ALUMINUM OXIDE MEMBRANE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2010-06-17 | — | — | US | disclosed |
| US-20100124037-A1 | THERMOSETTING COMPOSITION AND PRINTED CIRCUIT BOARD USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-20 | — | — | US | disclosed |
| US-7655155-B2 | Liquid crystal thermoset monomer or oligomer, thermosetting liquid crystal polymer composition comprising the same and printed circuit board using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-02-02 | — | — | US | disclosed |
| US-20090224203-A1 | LIQUID CRYSTAL THERMOSET MONOMER OR OLIGOMER, THERMOSETTING LIQUID CRYSTAL POLYMER COMPOSITION COMPRISING THE SAME AND PRINTED CIRCUIT BOARD USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-09-10 | — | — | US | disclosed |
| US-6709679-B2 | CONSISTING OF NATIVE OR THIOLATED TRANSFERRIN OR ALBUMIN OR OF POLYETHYLENE GLYCOL WITH ATLEAST ONE MERCAPTAN, HYDROXY OR AMINE GROUP AND CYTOSTATIC COMPOUNDS DERIVED THROUGH MALEINIMIDE OR HYDROXYSUCCINIMIDE ESTER COMPOUNDS | KRATZ FELIX (DE) | 2004-03-23 | — | — | US | disclosed |
| US-20020019343-A1 | Antineoplastic conjugates of transferrin, albumin and polyethylene glycol | KRATZ FELIX (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6310039-B1 | TUMOR-INHIBITING CONJUGATES OF PROTEINS AND POLYMERS CONSISTING OF A SUITABLE CARRIER SYSTEM AND CYTOSTATIC COMPOUNDS | KRATZ FELIX (DE) | 2001-10-30 | — | — | US | disclosed |
| US-6001958-A | POLYMER HAS ON AT LEAST TWO OF ITS ENDS, AT LEAST ONE REACTIVE END GROUP OF A DIFFERENT CHEMICAL TYPE FROM THAT OF THE GROUP PREDOMINANTLY USED IN POLYMERIZATION AND THE PREPARATION OF A POLYMER SKELETON. | FLAMEL TECHNOLOGIES (FR) | 1999-12-14 | — | — | US | disclosed |
| US-5811507-A | Polyesterimides for use in linear and/or non-linear optics, and one method for preparing same | FLAMEL TECHNOLOGIES (FR) | 1998-09-22 | — | — | US | disclosed |
| WO-1996000395-A1 | EVALUATION OF BLOOD COAGULATION ACTIVITY | CHEMTRAK, INC. (US) | 1996-01-04 | — | — | WO | disclosed |
| US-4269966-A | A MIXTURE OF AN ACRYLIC COMPOUND CONTAINING IMIDE, AMIDE, AND AN AMINE GROUP; MOLDING MATERIAL; CROSSLINKED, INSOLUBLE, INFUSIBLE POLYMER | TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) | 1981-05-26 | — | — | US | disclosed |
| US-4239883-A | INFUSIBLE AND INSOLUBLE | TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) | 1980-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019343-A1 | Antineoplastic conjugates of transferrin, albumin and polyethylene glycol | TFRC, ALB, FOLR1 | ALDH1A1 2933/4885TLR9 155/4885HSP90AA1 286/4885 |
| US-20090224203-A1 | LIQUID CRYSTAL THERMOSET MONOMER OR OLIGOMER, THERMOSETTING LIQUID CRYSTAL POLYMER COMPOSITION COMPRISING THE SAME AND PRINTED CIRCUIT BOARD USING THE SAME | MLLT1, RCC1, CNOT1 | ALDH1A1 2509/4885TLR9 2254/4885HSP90AA1 1509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.